PL3042648T3 - Granulat do podawania bezpośredniego o opóźnionym uwalnianiu substancji czynnej - Google Patents

Granulat do podawania bezpośredniego o opóźnionym uwalnianiu substancji czynnej

Info

Publication number
PL3042648T3
PL3042648T3 PL15202259T PL15202259T PL3042648T3 PL 3042648 T3 PL3042648 T3 PL 3042648T3 PL 15202259 T PL15202259 T PL 15202259T PL 15202259 T PL15202259 T PL 15202259T PL 3042648 T3 PL3042648 T3 PL 3042648T3
Authority
PL
Poland
Prior art keywords
granulate
direct
retarded agent
retarded
agent
Prior art date
Application number
PL15202259T
Other languages
English (en)
Inventor
Klaus Dandl
Josef HAALA
Original Assignee
Hermes Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hermes Arzneimittel Gmbh filed Critical Hermes Arzneimittel Gmbh
Publication of PL3042648T3 publication Critical patent/PL3042648T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15202259T 2014-12-23 2015-12-23 Granulat do podawania bezpośredniego o opóźnionym uwalnianiu substancji czynnej PL3042648T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14200223 2014-12-23
EP15202259.6A EP3042648B1 (de) 2014-12-23 2015-12-23 Direktgranulat mit retardiertem wirkstoff

Publications (1)

Publication Number Publication Date
PL3042648T3 true PL3042648T3 (pl) 2019-12-31

Family

ID=52144587

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15202259T PL3042648T3 (pl) 2014-12-23 2015-12-23 Granulat do podawania bezpośredniego o opóźnionym uwalnianiu substancji czynnej

Country Status (7)

Country Link
EP (1) EP3042648B1 (pl)
ES (1) ES2743785T3 (pl)
HR (1) HRP20191518T1 (pl)
HU (1) HUE045054T2 (pl)
PL (1) PL3042648T3 (pl)
PT (1) PT3042648T (pl)
RS (1) RS59176B1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220249371A1 (en) * 2021-02-08 2022-08-11 Capsugel Belgium Nv Extended Release Vitamin C and Manufacturing Thereof
EP3922243A3 (de) 2021-10-04 2022-04-20 HERMES PHARMA GmbH Direktgranulat mit kombination von retardiertem und schnellfreisetzendem magnesium

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL296020A (pl) 1962-08-16
JP2650498B2 (ja) 1990-02-20 1997-09-03 日本油脂株式会社 飼料用ビタミンｃ被覆製剤、その製造方法および用途
JP3122510B2 (ja) 1992-02-18 2001-01-09 日清製粉株式会社 ビタミンｃ顆粒
JP2003526619A (ja) 1999-03-16 2003-09-09 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング イソケルセチンと持続放出型のアスコルビン酸を含む組成物
AU4428000A (en) 1999-05-14 2000-12-05 Coraltis Ltd. Pulse-delivery oral compositions

Also Published As

Publication number Publication date
HRP20191518T1 (hr) 2019-11-29
EP3042648B1 (de) 2019-06-05
PT3042648T (pt) 2019-09-23
ES2743785T3 (es) 2020-02-20
HUE045054T2 (hu) 2019-12-30
RS59176B1 (sr) 2019-10-31
EP3042648A1 (de) 2016-07-13

Similar Documents

Publication Publication Date Title
ZA201606906B (en) Modified j-chain
PT3145354T (pt) Capacete
GB201405706D0 (en) Software protection
AU357292S (en) Helmet
PL3238826T3 (pl) Granulator
GB201507753D0 (en) New compounds and uses
GB201504763D0 (en) Compounds and uses
GB2540238B (en) Helmet
GB201402553D0 (en) Helmet
IL249075A0 (en) agent for fluoroalkylation
GB201419650D0 (en) Modified heterocyclase
PT3042648T (pt) Granulado direto com ingrediente ativo de libertação retardada
SG11201607674SA (en) Retinoic-acid-producing agent
GB2557748B (en) Helmet
AU2015264V (en) ValleyLights Trachelospermum jasminoides
GB201401800D0 (en) Margins
TWM490242U (en) Protection structure
AU358117S (en) Streetlight
AU358177S (en) Streetlight
AU358178S (en) Streetlight
GB201407596D0 (en) New compounds and uses
GB201407599D0 (en) New compounds and uses
GB201507752D0 (en) New compounds and uses
GB201402467D0 (en) New Compounds and uses
GB201421423D0 (en) Helmet